# Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rapidly-increasing-off-label-use-of-rituximab-in-multiple-sclerosis-in-sweden/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shala Ghaderi Berntsson,Anders Kristoffersson,I. Boström,A. Feresiadou,Joachim Burman,Anne‐Marie Landtblom |
| Citations | 67 |
| DOI | 10.1111/ane.12963 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2803602440 |
| PMID | 29797711 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Shala Ghaderi Berntsson](https://scholariq.org/researchers/shala-ghaderi-berntsson/)

## Paper journal

- [Acta Neurologica Scandinavica](https://scholariq.org/journals/acta-neurologica-scandinavica/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.